Signed Into Law
Signed September 17, 2025Effective 2025-09-01
HB25

2nd Special Session

Relating to a pharmacist's authority to dispense ivermectin without a prescription.

Government Affairs & Regulatory Compliance Analysis

Business Impact

Who HB25 Affects

Regulatory Priority: moderate

Notable regulatory updates (effective 2025-09-01). Consider how these changes may affect your operations.

Estimated Cost Impact

Need Government Relations Support?

JD Key Consulting provides government affairs and regulatory strategy services. We help businesses navigate Texas agencies, understand legislative impacts, and advocate for their interests.

Need Help Navigating This Legislation?

JD Key Consulting provides strategic guidance on Texas regulatory compliance and legislative impact for your business.

01

Compliance Analysis

Key implementation requirements and action items for compliance with this legislation

Immediate Action Plan

Operational Changes Required

Strategic Ambiguities & Considerations

Need Compliance Guidance on This Legislation?

Schedule a Consultation

Information presented is for general knowledge only and is provided without warranty, express or implied. Consult qualified government affairs professionals and legal counsel before making compliance decisions.

02
03
Quick Reference

Frequently Asked Questions

Common questions about HB25

Q

What does Texas HB25 do?

Texas pharmacists are granted the authority to dispense ivermectin without a prescription, shifting the liability and clinical assessment burden from physicians to pharmacy operations. While the law is enacted, you cannot operationalize this service until the Texas State Board of Pharmacy (TSBP) releases mandatory standardized protocols.

Q

Who authored HB25?

HB25 was authored by Texas Representative Joanne Shofner during the 2nd Special Session.

Q

When was HB25 signed into law?

HB25 was signed into law by Governor Greg Abbott on September 17, 2025.

Q

Which agencies enforce HB25?

HB25 is enforced by Texas State Board of Pharmacy.

Q

How significant are the changes in HB25?

The regulatory priority for HB25 is rated as "moderate". Businesses and organizations should review the legislation to understand potential impacts.

Q

What is the cost impact of HB25?

The cost impact of HB25 is estimated as "low". This may vary based on industry and implementation requirements.

Q

What topics does HB25 address?

HB25 addresses topics including health care providers, health, health--general, occupational regulation and occupational regulation--health occupations.

Q

What are the key dates for HB25?

Key dates for HB25: Effective date is 2025-09-01. Rulemaking: Must issue written standardized procedures or protocols and may adopt necessary rules to govern the dispensing of ivermectin without a prescription. (Prior to implementation). Consult with legal counsel regarding applicability.

Q

Which Texas businesses are affected by HB25?

HB25 primarily affects healthcare providers and medical facilities. These businesses should review the legislation with their legal and compliance teams to understand potential impacts.

Legislative data provided by LegiScanLast updated: January 11, 2026